10030-93-0 Usage
General Description
TRI-ACETYL PYRIDOXINE is a chemical compound that is derived from vitamin B6. It is a water-soluble vitamin that plays a crucial role in various physiological functions such as protein synthesis, metabolism, and nervous system development. TRI-ACETYL PYRIDOXINE is a form of pyridoxine that has been acetylated three times, making it more stable and bioavailable than its natural form. It is commonly used as a supplement to treat vitamin B6 deficiency and is also being researched for its potential therapeutic benefits in treating a variety of conditions such as epilepsy, diabetes, and cardiovascular disease. Overall, TRI-ACETYL PYRIDOXINE is an important compound with potential health benefits and applications in the medical field.
Check Digit Verification of cas no
The CAS Registry Mumber 10030-93-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,0,3 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 10030-93:
(7*1)+(6*0)+(5*0)+(4*3)+(3*0)+(2*9)+(1*3)=40
40 % 10 = 0
So 10030-93-0 is a valid CAS Registry Number.
10030-93-0Relevant articles and documents
Vitamin B6; A new synthesis by Diels-Alder reaction
Boell,Koenig
, p. 1657 - 1664 (1979)
-
-
Harris et al.
, p. 3198,3202 (1940)
-
MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME
-
Page/Page column 118, (2019/01/06)
Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.
METHODS FOR THE SYNTHESIS OF PYRIDOXAMINE
-
Page/Page column 18, (2008/06/13)
The invention provides non-oxidative methods for the large scale manufacture of pyridoxamine (I) (4-aminomethyl-3-hydroxy-5-hydroxymethyl-2-methylpyridine): Formula (I), and salts thereof. The invention also provides intermediate compounds for the synthesis of pyridoxamine, as well as compositions and methods for the treatment and/or prevention of conditions associated with the formation of post-Amadori advanced glycation end-products.
